COMPASS THERAPEUTICS, INC. Payments of Stock Issuance Costs
COMPASS THERAPEUTICS, INC. (CMPX) reported Payments of Stock Issuance Costs of $8.64 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-05
- COMPASS THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00.
- COMPASS THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2025-09-30 was $8.64M, a 431800.00% increase year-over-year.
- COMPASS THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2025-06-30 was $0.00.
- COMPASS THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2025 was $8.64M, a 1490.79% increase from fiscal 2024.
- COMPASS THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2024 was $543.00K, a 477.66% increase from fiscal 2023.
- COMPASS THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2023 was $94.00K, a 81.01% decline from fiscal 2022.
- COMPASS THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2022 was $495.00K, a 76.16% increase from fiscal 2021.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $8.64M derived: sum of 2 quarters · filed 2026-03-05 | $8.64M derived: sum of 3 quarters · filed 2026-03-05 | $8.64M 10-K · filed 2026-03-05 |
| 2025-09-30 | $8.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $8.64M derived: sum of 2 quarters · filed 2025-11-05 | $8.64M 10-Q · filed 2025-11-05 | $8.64M derived: sum of 4 quarters · filed 2026-03-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | -$2.00K derived: sum of 3 quarters · filed 2026-03-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-05 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | -$2.00K derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | -$1.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | -$1.00K derived: sum of 3 quarters · filed 2026-03-05 | $543.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.00K derived: sum of 2 quarters · filed 2025-11-05 | $545.00K 10-Q · filed 2025-11-05 | $544.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $543.00K 10-Q · filed 2025-08-11 | $542.00K derived: sum of 3 quarters · filed 2025-08-11 | $542.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $544.00K 10-Q · filed 2025-05-08 | $543.00K derived: sum of 2 quarters · filed 2025-05-08 | $543.00K derived: sum of 3 quarters · filed 2025-05-08 | $638.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.00K derived: sum of 2 quarters · filed 2025-02-27 | $94.00K derived: sum of 3 quarters · filed 2025-02-27 | $94.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $95.00K derived: sum of 2 quarters · filed 2024-11-12 | $95.00K 10-Q · filed 2024-11-12 | $590.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $95.00K 10-Q · filed 2024-08-12 | $590.00K derived: sum of 3 quarters · filed 2024-08-12 | $590.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | $495.00K derived: sum of 2 quarters · filed 2024-05-13 | $495.00K derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $495.00K derived: sum of 2 quarters · filed 2024-03-21 | $495.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $281.00K derived: sum of 2 quarters · filed 2023-03-15 | $281.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $802.00K derived: sum of 2 quarters · filed 2022-03-18 | $6.32M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $802.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $6.32M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $5.52M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |